Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraocular minocycline for the treatment of ocular pythiosis.
Ros Castellar F, Sobrino Jiménez C, del Hierro Zarzuelo A, Herrero Ambrosio A, Boto de Los Bueis A. Ros Castellar F, et al. Am J Health Syst Pharm. 2017 Jun 1;74(11):821-825. doi: 10.2146/ajhp160248. Am J Health Syst Pharm. 2017. PMID: 28546303
Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy.
Sobrino Jiménez C, Romero-Garrido JA, García-Martín Á, Quintana-Díaz M, Jiménez-Vicente C, González-Del Valle L, Herrero Ambrosio A, Benedí-González J. Sobrino Jiménez C, et al. Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e66-e71. doi: 10.1136/ejhpharm-2019-002114. Epub 2020 Jun 26. Eur J Hosp Pharm. 2021. PMID: 32591479 Free PMC article.
Real-World Experience with Two-Drug Regimens in HIV-1-Infected Patients Beyond the Indication of Clinical Trials: 48 Weeks' Results.
Arancón Pardo A, Moreno Palomino M, Jiménez-Nácher I, Moreno F, González Fernández MÁ, González-García J, Herrero Ambrosio A. Arancón Pardo A, et al. Among authors: herrero ambrosio a. AIDS Res Hum Retroviruses. 2021 Oct;37(10):761-767. doi: 10.1089/AID.2021.0041. Epub 2021 Sep 16. AIDS Res Hum Retroviruses. 2021. PMID: 34465135
Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?
García Trevijano Cabetas M, Escario-Gómez M, González-Del Valle L, Sobrino Jiménez C, Bilbao Gomez-Martino C, Romero-Garrido JA, Benedi-González J, Espinosa Arranz E, Díaz Almirón M, Herrero Ambrosio A. García Trevijano Cabetas M, et al. Among authors: herrero ambrosio a. Eur J Hosp Pharm. 2023 Sep;30(5):268-272. doi: 10.1136/ejhpharm-2021-002798. Epub 2021 Oct 7. Eur J Hosp Pharm. 2023. PMID: 34620687
Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation.
Herranz-Pinto P, Alonso-Pacheco ML, Feltes-Ochoa R, Mayor-Ibarguren A, Servera-Negre G, Busto-Leis JM, Gonzalez-Fernández MA, Herrero-Ambrosio A. Herranz-Pinto P, et al. Among authors: herrero ambrosio a. Clin Drug Investig. 2023 Jul;43(7):517-527. doi: 10.1007/s40261-023-01280-9. Epub 2023 Jul 4. Clin Drug Investig. 2023. PMID: 37402097 Free PMC article.
[Incorporation of patient-reported outcomes into pharmacy and dermatology departments, in psoriasis and atopic dermatitis patients, as a tool to improve the healthcare quality and health outcomes].
González-Fernández MÁ, Herranz-Pinto P, Alonso-Pacheco ML, Mateo-Salillas C, Hoyo-Muñoz Á, Jiménez-Nácher I, Moreno-Ramos F, Herrero-Ambrosio A. González-Fernández MÁ, et al. Among authors: herrero ambrosio a. J Healthc Qual Res. 2024 Jan-Feb;39(1):13-22. doi: 10.1016/j.jhqr.2023.10.004. Epub 2023 Oct 31. J Healthc Qual Res. 2024. PMID: 37919175 Spanish.
Vein irritation from i.v. pentamidine.
Herrero Ambrosio A, González del Valle L, González García J. Herrero Ambrosio A, et al. Am J Health Syst Pharm. 1996 Dec 1;53(23):2881-2. doi: 10.1093/ajhp/53.23.2881. Am J Health Syst Pharm. 1996. PMID: 8957350 No abstract available.
25 results